CRYSTALLINE FORM AND SALT OF 3-(3,5-DICHLORO-4- HYDROXYBENZOYL)-1,1-DIOOXO-2,3-DIHYDRO-1,3- BENZOTHIAZOLE
CY1126305T1Undetermined Publication Date: 2026-07-31FUJI YAKUHIN CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100522T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-04-28
- Filing Date
- 2023-09-25
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-09-25
Abstract
Provided are: a pharmaceutical composition containing a type I crystal of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole, a type II crystal of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole, a hydrate of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole, a salt thereof, and a pharmaceutically acceptable carrier and a method for preparing the same.
Need to check novelty before this filing date? Find Prior Art